BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Tuesday 12 May 2020
Clyraguard Featured on NBC News Affiliate Segment for its Role in Protecting Healthcare Workers
Very exciting news!
BioLargo's subsidiary Clyra Medical Technologies (www.clyramedical.com) has been featured on an NBC-2 News segment about Clyraguard's role in protecting healthcare workers as a front-line defense against SARS-CoV-2, the virus that causes COVID-19.
Clyraguard is a disinfectant and germicide designed for use directly on personal protective equipment (PPE) to provide additional viricidal protection and to prolong the life of PPE. Clyraguard is proven effective against SARS-CoV-2 and is safe for use on and near skin. Clyra is also donating hundreds of bottles of Clyraguard Disinfecting Personal Protective Spray to Naples Community Hospital in Naples, FL.
Learn more about Clyraguard at www.clyramedical.com/clyraguard. More information will be coming soon!
For more information about how to obtain ClyraGuard for yourself email Dennis.Calvert@BioLargo.com.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment